Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS

Centres Of Excellence

Our Centres of Excellence bring together multidisciplinary teams to deliver precise diagnosis, advanced treatments, and superior outcomes across a wide spectrum of medical specialties.

Medical professionals in hospital setting

OVERVIEW

Intensity-modulated radiation therapy (IMRT) is a specialized technique within radiation oncology used to treat primary and metastatic malignancies. The fundamental goal of IMRT is to achieve optimal tumor control probability while minimizing normal tissue complication probability. Traditional radiation therapy delivers uniform beams from fixed angles, which can expose nearby healthy tissues to significant radiation. In contrast, IMRT uses advanced software and moving lead leaves within a linear accelerator (LINAC) to alter beam intensity dynamically. This creates a custom three-dimensional dose distribution that conforms tightly to the tumor shape.

According to the American Society for Radiation Oncology (ASTRO) and the National Comprehensive Cancer Network (NCCN) guidelines, IMRT is considered a standard of care for tumors located near radio-sensitive organs. These include cancers of the head and neck, prostate, central nervous system, gastrointestinal tract, and gynecologic organs. The treatment is typically delivered in daily fractions over four to eight weeks, depending on the anatomical site, clinical stage, and treatment intent.

PROCEDURE

IMRT is administered in daily outpatient sessions over two to eight weeks. The patient lies on a motorized treatment couch using custom positioning devices to maintain precise alignment. Prior to beam delivery, onboard image-guided radiation therapy (IGRT) captures imaging to verify accuracy within millimeters. The linear accelerator rotates around the patient, moving internal multileaf collimators to deliver non-uniform radiation beamlets from multiple angles. The patient feels no pain during delivery. Each session takes 15 to 30 minutes.

BENEFITS

Evidence-based clinical advantages of intensity-modulated radiation therapy over conventional external beam techniques include:

  • Enhanced Precision and Target Conformity: Delivers high-dose radiation tightly to complex tumor geometries.
  • Organ-at-Risk Sparing: Reduces radiation exposure to critical structures such as the spinal cord, salivary glands, rectum, and optic pathways.
  • Dose Escalation Capabilities: Allows higher total radiation doses to the tumor without exceeding normal tissue tolerance levels, improving local control rates (ASTRO Guidelines 2023).
  • Reduced Acute and Chronic Toxicity: Lowers the incidence of severe side effects, such as permanent dry mouth in head and neck cancers and rectal bleeding in prostate cancer treatment.
  • Simultaneous Integrated Boost (SIB): Permits delivery of different dose levels to distinct target regions within a single daily treatment session, shortening the overall duration of therapy.

RECOVERY

Recovery from intensity-modulated radiation therapy occurs gradually over weeks to months. During therapy, patients experience cumulative acute effects, including local fatigue and skin inflammation. These side effects typically peak one to two weeks after completing therapy before steadily improving.

  • Weeks 1–2 Post-Treatment: Acute tissue inflammation and fatigue begin to subside. Skin erythema clears, and acute mucosal reactions start to heal.
  • Weeks 4–8 Post-Treatment: Most acute side effects resolve. Taste perception, bowel habits, and urinary frequency return toward baseline levels.
  • Months 3–6 Post-Treatment: Initial post-treatment surveillance imaging (CT, MRI, or PET-CT) is performed to evaluate treatment response and document baseline anatomical changes.
  • Long-Term (1 Year and Beyond): Patients are monitored for late radiation effects, such as localized tissue fibrosis or vascular changes, through regular follow-up visits.

WHAT WE TREAT

Intensity-modulated radiation therapy is indicated for malignant and select non-malignant conditions where high precision is required to spare adjacent critical structures:

  • Head and Neck Cancers: Squamous cell carcinomas of the nasopharynx, oropharynx, larynx, and oral cavity, sparing salivary glands to prevent permanent dry mouth.
  • Prostate Cancer: Adenocarcinoma of the prostate, enabling dose escalation while shielding the rectum and urinary bladder.
  • Central Nervous System Tumors: Gliomas, meningiomas, and brain metastases adjacent to the optic nerve, brainstem, and spinal cord.
  • Gastrointestinal Cancers: Esophageal, pancreatic, rectal, and anal cancers, protecting functional liver, kidney, and bowel tissues.
  • Gynecologic Cancers: Cervical and endometrial malignancies, minimizing radiation exposure to small bowel loops.
  • Thoracic Cancers: Non-small cell lung cancer and mediastinal tumors near the heart and healthy lung tissue.
  • Pediatric Malignancies: Selected solid tumors where reducing integral radiation dose minimizes long-term developmental complications.

PREPARATION

Preparation begins with a planning session known as CT simulation. Custom thermoplastic masks or body molds are crafted to hold the patient still during treatment. CT imaging is acquired in the treatment position, sometimes combined with MRI or PET scans. Patients receive site-specific guidelines, such as maintaining a full bladder or empty rectum for pelvic treatments. Tattoo marks or skin lines are applied to assist daily technical alignment.

RISKS

Side effects of IMRT depend on the body area treated and are classified as acute or chronic. Common acute effects include temporary skin redness, fatigue, and localized tissue inflammation. Uncommon site-specific effects include rectal inflammation, difficulty swallowing, or urinary frequency. Rare but serious long-term risks include severe tissue fibrosis, organ perforation, chronic salivary gland dysfunction, and a slight risk of secondary primary malignancies years after exposure.

JOURNEY

The patient clinical journey for intensity-modulated radiation therapy involves four structured phases:

  • Phase 1: Diagnostic Workup and Consultation: The radiation oncologist reviews diagnostic imaging, biopsy reports, and staging data. The clinical team confirms treatment intent, whether curative (definitive) or palliative, and discusses potential risks and outcomes.
  • Phase 2: Radiation Simulation and Treatment Planning: A high-resolution computed tomography (CT simulation) scan is conducted using custom immobilization devices such as thermoplastic masks or body molds. Radiation planners use computerized inverse planning algorithms to define target tumor volumes and establish safety constraints for surrounding healthy organs.
  • Phase 3: Daily Treatment Execution: Treatment is delivered on an outpatient basis five days per week for two to eight weeks. Each daily session lasts 15 to 30 minutes, during which onboard image-guided radiation therapy (IGRT) aligns the patient before the machine delivers targeted radiation beams.
  • Phase 4: Acute Recovery and Surveillance: Post-treatment surveillance involves physical examinations, laboratory studies, and periodic restaging scans to evaluate tumor response and manage potential acute or long-term side effects.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Hisar Intercontinental Hospital

Hisar Intercontinental Hospital

Saray Mah. Siteyolu Cad. No:7, Umraniye, 34768, Istanbul, Turkey

Medical Park Group, Istanbul

Medical Park Group, Istanbul

Fahrettin Kerim Gokay Cad. Tıbbiye Cd., Kadikoy, Istanbul, Turkey

Emsey Hospital, Pendik, Istanbul

Emsey Hospital, Pendik, Istanbul

Çamlık, Selçuklu Cd. No:22, 34912 Pendik/İstanbul, Türkiye

LIV Hospital, Istanbul

LIV Hospital, Istanbul

American Hospital, Istanbul

American Hospital, Istanbul

Guzelbahce Sk. No:20, 34365, Nisantasi, Istanbul, Turkey

Memorial Hospitals Group

Memorial Hospitals Group

Burhaniye, Nagehan Sokağı No:4/A D:1, 34676 Üsküdar/İstanbul, Türkiye

Florence Nightingale Hospital Istanbul

Florence Nightingale Hospital Istanbul

Abide-i Hürriyet Cd No:166, 34381 Sisli, Istanbul

Medicana International Hospital, Istanbul

Medicana International Hospital, Istanbul

Halit Ziya Turkkani Mah. Medikal Park Cd. No:1, Beylikdüzü, İstanbul

Okan University Hospital Istanbul

Okan University Hospital Istanbul

Icmeler Mah. Aydınlıyolu Cd. No:2, 34947 Icmeler-Tuzla, Istanbul

Kolan International Hospital, Istanbul

Kolan International Hospital, Istanbul

Kaptanpasa Mah. Okmeydan Kavsagi, Darulaceze Cd. No:14, 34384 Sisli, Istanbul

Al Zahra Hospital, Dubai

Al Zahra Hospital, Dubai

Sheikh Zayed Road, Al Barsha 1, Dubai, UAE

Burjeel Medical City, Abu Dhabi

Burjeel Medical City, Abu Dhabi

28th Street, Mohammed Bin Zayed City, Abu Dhabi, UAE

Burjeel Hospital, Dubai

Burjeel Hospital, Dubai

Dubai, UAE (part of Burjeel Holdings network)

King's College Hospital, Dubai

King's College Hospital, Dubai

Dubai Hills, Mohammed Bin Rashid City, Dubai, UAE

Neuro Spinal Hospital (NSH), Dubai

Neuro Spinal Hospital (NSH), Dubai

Dubai Science Park, Umm Suqeim St, Al Barsha South, Dubai, UAE

HMS Al Garhoud Hospital, Dubai

HMS Al Garhoud Hospital, Dubai

Al Garhoud Street, Al Garhoud, Dubai, UAE

Canadian Specialist Hospital, Dubai

Canadian Specialist Hospital, Dubai

Abu Hail Street 269/1, Canadian Specialist Hospital Building, Hor Al Anz East, Deira, Dubai, UAE

NMC Royal Women's Hospital, Abu Dhabi

NMC Royal Women's Hospital, Abu Dhabi

Tower B, Mohammed bin Zayed Stadium, Al Jazira Club, Opposite Dusit Thani, Muroor Road, Abu Dhabi, UAE

NMC Specialty Hospital, Al Nahda, Dubai

NMC Specialty Hospital, Al Nahda, Dubai

7A St, Al Qusais, Al Nahda 2, next to Bait Al Khair Building, Dubai

Bangkok Hospital, Thailand

Bangkok Hospital, Thailand

2 Soi Soonvijai 7, New Petchburi Road, Huay Khwang, Bangkok 10310, Thailand

Booking With DIVINHEAL

Get a free consultation to understand your treatment options